The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Van Bael & Bellis

GLAVERBEL BUILDING, CHAUSSÉE DE LA HULPE, 166 TERHULPSESTEENWEG, 1170 BRUSSELS, BELGIUM
Tel:
Work +32 2 647 73 50
Fax:
Fax +32 2 640 64 99
Email:
Web:
www.vbb.com
Brussels, Geneva

Michael Clancy

Tel:
Work +32 2 647 73 50
Email:
Van Bael & Bellis

Work Department

Competition

Position

Senior Counsel Michael Clancy focuses on EU competition law, including advising clients on antitrust and cartel investigations, distribution, R&D collaborations, patent and trademark licensing and other commercial agreements, the clearance of mergers and joint ventures, and abuse of dominance issues. 

Michael has significant experience in the life sciences (pharmaceuticals, biotech, and medical devices), cosmetics, and software & technology sectors.

His notable experience includes successfully defending clients in antitrust investigations by the European Commission in both the pharmaceutical and cosmetics sectors, his ongoing work on the appeal against the Commission's first decision on reverse-payment patent settlements in the pharma industry, as well as his ongoing work defending clients in the Commission’s auto-parts investigation. 

Michael also has in-depth experience advising a range of clients on their distribution, licensing, and other collaboration agreements.

Languages

Michael speaks English.

Member

Member of the State Bar of New York, USA. Associate Member of the Brussels Bar.

Education

Yale Law School – J.D., 2003; University of Dayton – B.A. in Mechanical Engineering, 2000


Belgium: Industry focus

Healthcare and life sciences

Within: Next generation lawyers

Michael Clancy - Van Bael & Bellis

Within: Healthcare and life sciences

Van Bael & Bellis has a broad life sciences practice and is particularly prominent in issues concerning ethical rules, clinical trials, advertising and pricing and reimbursement. Its client base of leading multinational life sciences companies also turn to the team for a range of EU and Belgian regulatory advice. Catherine Longeval recently advised the European arm of a US biotech company on the restructuring of its distribution chain. David Hull and counsel Michael Clancy represented two parties in a landmark case before the EU Court of Justice concerning reverse payment patent settlements. Peter L’Ecluse is another key contact.

[back to top]


Back to index

Legal Developments in Belgium

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to